Joshua Z. Goldenberg, ND, answered our questions about his team’s study aimed to assess the efficacy and safety of biofeedback-based interventions for treating irritable bowel syndrome among adults and...
Michael Camilleri, MD, from the Mayo Clinic, answers our questions about his research on fecal bile acids and fecal fat as potential biomarkers for irritable bowel syndrome, the importance of individualized...
Magnus Simrén, MD, PhD, answers our questions about his research that assessed whether human milk oligosaccharides could improve bowel symptoms in patients with irritable bowel syndrome.
Sarah Ballou, PhD, answers our questions about her research on the effects of IBS on daily function between disease subtypes, as well as about current IBS management challenges and more.
